Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria

Dermatology

Volumn 226, Issue 4, 2013, Pages 371-379

  Koti, I ^a,e   Weller, K ^e   Makris, M ^a,e   Tiligada, E ^a,b   Psaltopoulou, T ^b   Papageorgiou, C ^c   Baiardini, I ^f   Panagiotakos, D ^d   Braido, F ^f   Maurer, M ^e  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Department of Pharmacology ^*  (Greece)

^c UNIVERSITY MENTAL HEALTH RESEARCH INSTITUTE   (Greece)

^d HAROKOPIO UNIVERSITY   (Greece)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

Chronic spontaneous urticaria; Chronic Urticaria Quality of Life Questionnaire; Dermatology Life Quality Index; Disease activity; Quality of life; Urticaria Activity Score

Indexed keywords

ADULT; ARTICLE; CHRONIC SPONTANEOUS URTICARIA; CHRONIC URTICARIA; CLINICAL PRACTICE; COMORBIDITY; CONVERGENT VALIDITY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE ACTIVITY; DISEASE DURATION; EATING; FEMALE; GREECE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MENTAL HEALTH; MOOD; NERVOUSNESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; SIDE EFFECT; SLEEP; SOCIAL INTERACTION; SWELLING; CHRONIC URTICARIA QUALITY OF LIFE QUESTIONNAIRE; CRONBACH ALPHA COEFFICIENT; EMOTION; LEISURE; SPORT; SYMPTOM; URTICARIA; CHRONIC DISEASE; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY;

ADULT; CHRONIC DISEASE; EATING; EMOTIONS; FEMALE; GREECE; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SLEEP; URTICARIA;

EID: 84884262875     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000351711     Document Type: Article

References (30)

1. Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M: Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol 2010; 35: 869-873.
2. Gaig P, Olona M, Muñoz Lejarazu D, Caballero MT, Dominguez FJ, Echechipia S, Garcia Abujeta JL, Gonzalo MA, Lleonart R, Martinez-Cocera C, Rodriguez A, Ferrer M: Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol 2004; 14: 214-220.
3. Zuberbier T, Chantraine-Hess S, Hartmann K, Czarnetzki BM: Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol 1995; 75: 484-487.
4. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW: Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-1604.
5. Wedi B, Raap U, Kapp A: Chronic urticaria and infections. Curr Opin Allergy Clin Immunol 2004; 4: 387-396.
6. 2LEN task force report. Allergy 2011; 66: 317-330.
7. WHOQOL Group: Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res 1993; 2: 153-159.
8. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW: The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
9. Staubach P, Eckhardt-Henn A, Dechene M, Vonend A, Metz M, Magerl M, Breuer P, Maurer M: Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006; 154: 294-298.
10. Ozkan M, Oflaz SB, Kocaman N, Ozseker F, Gelincik A, Buyukozturk S, Ozkan S, Colakoglu B: Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2007; 99: 29-33.
11. Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, Braga M, Lombardi C, Fassio O, Canonica GW: A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005; 60: 1073-1078.
12. Valero A, Herdman M, Bartra J, Ferrer M, Jauregui I, Davila I, del Cuvillo A, Montoro J, Mullol J, Sastre J, Canonica GW, Baiardini I: Adaptation and validation of the Spanish version of the chronic urticaria quality of life questionnaire (CU-Q2oL). J Investig Allergol Clin Immunol 2008; 18: 426-432.
13. Mlynek A, Magerl M, Hanna M, Lhachimi S, Baiardini I, Canonica GW, Brzoza Z, Kasperska-Zajac A, Rogala B, Zalewska-Janowska A, Zuberbier T, Maurer M: The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009; 64: 927-936.
14. Brzoza Z, Badura-Brzoza K, Mlynek A, Magerl M, Baiardini I, Canonica GW, Weller K, Kocaturk E, Kalogeromitros D, Zalewska-Janowska A, Zuberbier T, Maurer M: Adaptation and initial results of the Polish version of the GA2LEN chronic urticaria quality of life questionnaire (CU-Q2oL). J Dermatol Sci 2011; 62: 36-41.
15. Kocaturk E, Weller K, Martus P, Aktas S, Kavala M, Sarigul S, Baiardini I, Canonica GW, Brzoza Z, Kalogeromitros D, Maurer M: Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity. Acta Derm Venereol 2012; 92: 419-425.
16. Dias GA, Pires GV, Valle SO, Franca AT, Papi JA, Dortas SD Jr, Levy SA, Baiardini I, Canonica GW: Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CUQ 2. oL. Allergy 2011; 66: 1487-1493.
17. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B, Maurer M: EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426.
18. Lennox RD, Leahy MJ: Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol 2004; 93: 142-146.
19. Bentler PM, Bonett DG: Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bull 1980; 88: 588-606.
20. Bollen KA: A new incremental fit index for general structural equation models. Sociol Methods Res 1989; 17: 303-316.
21. Browne MW, Cudeck R: Alternative ways of assessing model fit. Sociol Methods Res 1992; 21: 230-258.
22. Streiner DL, Norman GR: Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford, Oxford University Press, 1995.
23. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY: The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
24. 2LEN taskforce position paper. Allergy 2011; 66: 840-844.
25. 2LEN position paper. Allergy 2010; 65: 459-466.
26. Weller K, Church MK, Kalogeromitros D, Krause K, Magerl M, Metz M, Pisarevskaja D, Siebenhaar F, Maurer M: Chronic spontaneous urticaria: how to assess quality of life in patients receiving treatment. Arch Dermatol 2011; 147: 1221-1223.
27. Mazzotti E, Picardi A, Sampogna F, Sera F, Pasquini P, Abeni D: Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis. Br J Dermatol 2003; 149: 318-322.
28. Haeck IM, ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA, Knol MJ: Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2012; 26: 236-241.
29. Gray WN, Denson LA, Baldassano RN, Hommel KA: Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 1581-1586.
30. Antoniou C, Stefanaki I, Stratigos A, Moustou E, Vergou T, Stavropoulos P, Avgerinou G, Rigopoulos D, Katsambas AD: Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre. Br J Dermatol 2010; 162: 1117-1123.